1,070 results on '"Barker, Juliet N."'
Search Results
2. Racial/ethnic disparities in availability of volunteer unrelated donors for allogeneic transplantation
3. Analysis of disparities in time to allogeneic transplantation in adults with acute myelogenous leukemia
4. A phase 2 study of interleukin-22 and systemic corticosteroids as initial treatment for acute GVHD of the lower GI tract
5. Low-dose unfractionated heparin prophylaxis is a safe strategy for the prevention of hepatic sinusoidal obstruction syndrome after myeloablative adult allogenic stem cell transplant
6. Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR
7. Extended-duration letermovir prophylaxis for cytomegalovirus infection after cord blood transplantation in adults
8. The Simplified Comorbidity Index: a new tool for prediction of nonrelapse mortality in allo-HCT
9. Reduced-intensity conditioning hematopoietic stem cell transplantation for chronic lymphocytic leukemia and Richter's transformation
10. Guidelines for the Prevention and Management of Graft-versus-Host Disease after Cord Blood Transplantation
11. Guidelines for Adult Patient Selection and Conditioning Regimens in Cord Blood Transplant Recipients with Hematologic Malignancies and Aplastic Anemia
12. High progression-free survival after intermediate intensity double unit cord blood transplantation in adults
13. Guidelines for Cord Blood Unit Selection
14. Guidelines for Cord Blood Unit Thaw and Infusion
15. Incidence and Risk Factors for Acute and Chronic Kidney Injury after Adult Cord Blood Transplantation
16. Evaluation of Cord Blood Total Nucleated and CD34+ Cell Content, Cell Dose, and 8-Allele HLA Match by Patient Ancestry
17. Robust CD4+ T-cell recovery in adults transplanted with cord blood and no antithymocyte globulin
18. Analysis of the CD34+ cell to total nucleated cell content ratio of 619 transplanted and back-up cord blood units
19. Engraftment kinetics after transplantation of double unit cord blood grafts combined with haplo-identical CD34+ cells without antithymocyte globulin
20. Geriatric syndromes in 2-year, progression-free survivors among older recipients of allogeneic hematopoietic cell transplantation
21. Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation
22. Impact of geriatric vulnerabilities on allogeneic hematopoietic cell transplantation outcomes in older patients with hematologic malignancies
23. CD34+ cell content of 126 341 cord blood units in the US inventory: implications for transplantation and banking
24. Racial disparities in access to HLA-matched unrelated donor transplants: a prospective 1312-patient analysis
25. Burden and impact of multifactorial geriatric syndromes in allogeneic hematopoietic cell transplantation for older adults
26. Cell Dose and Immunogenetic Considerations in Cord Blood Transplantation
27. Lack of a significant pharmacokinetic interaction between letermovir and calcineurin inhibitors in allogeneic HCT recipients
28. Validation of an Algorithm to Predict the Likelihood of an 8/8 HLA-Matched Unrelated Donor at Search Initiation
29. Protective Factors in the Intestinal Microbiome Against Clostridium difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
30. Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with acute leukemia
31. The Simplified Comorbidity Index predicts non‐relapse mortality in reduced‐intensity conditioning allogeneic haematopoietic cell transplantation
32. Pathogenesis and outcome of VA1 astrovirus infection in the human brain are defined by disruption of neural functions and imbalanced host immune responses
33. A Chemotherapy-Only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit Antithymocyte Globulin Followed by Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplantations for the Treatment of Myeloid Malignancies
34. Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies
35. Prospective Evaluation of Unrelated Donor Cord Blood and Haploidentical Donor Access Reveals Graft Availability Varies by Patient Ancestry: Practical Implications for Donor Selection
36. Ex Vivo CD34+–Selected T Cell–Depleted Peripheral Blood Stem Cell Grafts for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Leukemia and Myelodysplastic Syndrome Is Associated with Low Incidence of Acute and Chronic Graft-versus-Host Disease and High Treatment Response
37. Hematopoietic Cell Transplantation Comorbidity Index Predicts Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Receiving CD34+ Selected Grafts for Allogeneic Hematopoietic Cell Transplantation
38. Gender disparities in allograft access due to HLA-sensitization in multiparous women
39. Cellular Therapy During COVID-19: Lessons Learned and Preparing for Subsequent Waves
40. Abstract A48: Aging-related, Senescence-associated Secretory Phenotype and Allogeneic Hematopoietic Cell Transplantation Outcomes in Older Adults
41. Association between non-European ancestry, low socioeconomic status, and receipt of HLA-disparate allografts in adult BMT recipients
42. Analysis of 372 Adult Allograft Recipients Reveals Associations between Non-European Ancestry, Low Socioeconomic Status, and Receipt of HLA-Disparate Grafts
43. Prospective Analysis to Determine Barriers to Allogeneic Hematopoietic Cell Transplantation in Patients with Newly Diagnosed and Relapsed Acute Leukemia
44. The Simplified Comorbidity Index Predicts Non-Relapse Mortality in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplant after Reduced-Intensity Conditioning
45. Insurance Barriers to High-Cost Anti-Infective Medications Post Allogeneic Hematopoietic Cell Transplant
46. An Optimized Search Prognosis Tool to Predict 8/8 HLA Allele-Matched Unrelated Donor Procurement
47. In Vivo T Cell Depletion with Myeloablative Regimens on Outcomes after Cord Blood Transplantation for Acute Lymphoblastic Leukemia in Children
48. Robust Vaccine Responses in Adult and Pediatric Cord Blood Transplantation Recipients Treated for Hematologic Malignancies
49. High Disease-Free Survival with Enhanced Protection against Relapse after Double-Unit Cord Blood Transplantation When Compared with T Cell–Depleted Unrelated Donor Transplantation in Patients with Acute Leukemia and Chronic Myelogenous Leukemia
50. Association between Nondominant Unit Total Nucleated Cell Dose and Engraftment in Myeloablative Double-Unit Cord Blood Transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.